…repurpose existing drugs to treat Covid-19, and that tools such as artificial intelligence (AI) would help to identify promising candidates quickly. Building on existing clinical experience and with safety profiles…

…and Gates Philanthropy Partners, as part of the Covid-19 Therapeutics Accelerator initiative, to progress a new class of Covid-19 therapeutics created using its artificial intelligence (AI) drug design platform. Genomics…

…throughput experimentation mean scientists must automate their workflows to ensure clean data is available to take advantage of advanced data analytics such as Artificial Intelligence (AI) and Machine Learning. Dotmatics’…

…Covid-19 therapeutics created using its artificial intelligence (AI) drug design platform. Exscientia has demonstrated proof-of-concept by using its AI platform to design a novel class of inhibitors targeting the SARS-CoV-2’s…

…artificial intelligence-aided computer programme. Our findings suggested that one of the compounds in green tea could combat the coronavirus behind Covid-19.” Dr Mohankumar emphasised that the research was still in…

…for connecting the instruments and automating data driven processes. A unified digital infrastructure allows for data to be collected and stored in a single data lake which allows artificial intelligence…

New research reveals that 50% of European and US pharmaceutical manufacturing companies know artificial intelligence (AI) can help bring new drugs to market more rapidly and securely, but 96% face…

…offer the prospect of tighter schedules and reduced costs for clinical trials – and also of reduced risk of failure, thanks to the potential of such technologies as artificial intelligence…

…rise of technology. Health / fitness devices, electronics patient records, health informatics and artificial intelligence have helped move data from person to clinician to researcher that has helped speed up…

Last month, the AI-driven pharma-tech company, Exscientia announced that the world’s first Alzheimer’s disease (AD) drug candidate designed by artificial intelligence (AI) was entering Phase I clinical trials. This is…